Incyte (INCY) Operating Income (2010 - 2026)
Incyte (INCY) posted Operating Income of $301.1 million for Q1 2026, down 10.34% on a QoQ basis from $335.9 million in Q4 2025, and up 46.77% year-over-year from $205.2 million in Q1 2025.
Incyte (INCY) Operating Income (2010 - 2026) Analysis & Trends
Incyte's Operating Income history runs 17 years deep, the most recent figure standing at $301.1 million for Q1 2026.
- Quarterly Operating Income rose 46.77% year-over-year to $301.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 822.38% YoY) and the FY2025 annual result came in at $1.5 billion, up 2368.56% from the prior year.
- Operating Income was $301.1 million for Q1 2026 at Incyte, down from $335.9 million in the prior quarter.
- Across five years, Operating Income topped out at $530.3 million in Q2 2025 and bottomed at -$478.1 million in Q2 2024.
- A 5-year average of $181.0 million and a median of $193.8 million in 2023 frame the typical range for Operating Income.
- Peak annual rise in Operating Income reached 271.01% in 2024, while the deepest fall reached 346.74% in 2024.
- Incyte's Operating Income stood at $70.1 million in 2022, then jumped by 167.17% to $187.3 million in 2023, then jumped by 61.0% to $301.5 million in 2024, then grew by 11.39% to $335.9 million in 2025, then dropped by 10.34% to $301.1 million in 2026.
- Business Quant data shows INCY's Operating Income at $301.1 million in Q1 2026, $335.9 million in Q4 2025, and $443.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn | 301.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301.12 Mn |
| Dec 31, 2025 | 335.86 Mn |
| Sep 30, 2025 | 443.52 Mn |
| Jun 30, 2025 | 530.31 Mn |
| Mar 31, 2025 | 205.17 Mn |
| Dec 31, 2024 | 301.51 Mn |
| Sep 30, 2024 | 146.09 Mn |
| Jun 30, 2024 | -478.13 Mn |
| Mar 31, 2024 | 91.90 Mn |
| Dec 31, 2023 | 187.27 Mn |
| Sep 30, 2023 | 214.71 Mn |
| Jun 30, 2023 | 193.78 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 70.09 Mn |
| Sep 30, 2022 | 138.38 Mn |
| Jun 30, 2022 | 254.43 Mn |
| Mar 31, 2022 | 116.54 Mn |
| Dec 31, 2021 | 110.73 Mn |
| Sep 30, 2021 | 235.41 Mn |
| Jun 30, 2021 | 140.84 Mn |